The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort

Cancer

Volumn 116, Issue 6, 2010, Pages 1572-1581

  Freedman, Neal D ^a   Lacey Jr , James V ^a   Hollenbeck, Albert R ^b   Leitzmann, Michael F ^c   Schatzkin, Arthur ^a   Abnet, Christian C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AARP   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Esophageal neoplasms; Estrogen replacement therapy; Head and neck neoplasms; Stomach neoplasms

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FEMALE GENITAL SYSTEM; FOLLOW UP; HEAD AND NECK CARCINOMA; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; UPPER GASTROINTESTINAL TRACT;

ADENOCARCINOMA; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HEALTH SURVEYS; HUMANS; MALE; MENSTRUATION; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK; SEX CHARACTERISTICS; SMOKING; UNITED STATES;

EID: 77949366041     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24880     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol. 2004;31:450-464.
3. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004;31:726-733.
4. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-2252.
5. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162:1050-1061.
6. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer. 2007; 110:1593-1601.
7. Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC. Alcohol and head and neck cancer risk in a prospective study. Br J Cancer. 2007;96:1469-1474.
8. Freedman ND, Chow WH, Gao YT, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007;56:1671-1677.
9. Frise S, Kreiger N, Gallinger S, Tomlinson G, Cotterchio M. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the Canadian National Enhanced Cancer Surveillance System. Ann Epidemiol. 2006;16:908-916.
10. Heuch I, Kvale G. Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control. 2000;11:869-874.
11. Inoue M, Ito LS, Tajima K, et al. Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer. 2002;97:833-838.
12. Kaneko S, Tamakoshi A, Ohno Y, Mizoue T, Yoshimura T. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control. 2003;14:53-59.
13. La Vecchia C, Negri E, Franceschi S, Parazzini F. Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993;53:215-219.
14. La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, DeCarli A. Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer. 1994;59:761-764.
15. Lindblad M, Garcia Rodriguez LA, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer. 2006;94:136-141.
16. Palli D, Cipriani F, DeCarli A, et al. Reproductive history and gastric cancer among post-menopausal women. Int J Cancer. 1994;56:812-815.
17. Persson C, Inoue M, Sasazuki S, et al. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev. 2008;17:345-353.
18. Corrao G, Zambon A, Conti V, et al. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol. 2008;19:150-155.
19. Bosetti C, Negri E, Franceschi S, et al. Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland. Br J Cancer. 2000;82:204-207.
20. Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La VC. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer. 2003;105:408-412.
21. Gallus S, Bosetti C, Franceschi S, et al. Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br J Cancer. 2001;85:341-345.
22. Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La VC. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev. 2003;12:514-517.
23. Suba Z. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res. 2007;13:195-202.
24. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154:1119-1125.
25. Michaud DS, Midthune D, Hermansen S, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. Journal of Registry Management. 2005;32:70-75.
26. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165: 1424-1433.
27. Lacey JV, Jr, Leitzmann MF, Chang SC, et al. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort. Cancer. 2007;109:1303-1311.
28. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society Series B-Statistical Methodology. 1972; 34:187.
29. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the timescale. Am J Epidemiol. 1997;145:72-80.
30. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365:1543-1551.
31. Prentice RL, Chlebowski RT, Stefanick ML, et al. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol. 2008;167:1207-1216.
32. Prentice RL, Chlebowski RT, Stefanick ML, et al. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol. 2008;167:1407-1415.
33. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350:991-1004.
34. Ritenbaugh C, Stanford JL, Wu L, et al. Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2008;17:2609-2618.